KEENOVA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

KEENOVA Trademark

Serial Number: 79444786

KEENOVA is a trademark filed by Mallinckrodt Pharmaceuticals Ireland Limited on December 15, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Mallinckrodt Pharmaceuticals Ireland Limited (7 trademarks)

College Business & Technology Park
Blanchardstown, Dublin 15 D15 TX2V , IE

Entity Type: 77

Trademark Details

Filing Date

December 15, 2025

Registration Date

Not Registered

Goods & Services

Healthcare management services, namely, providing administrative support services to physicians and healthcare providers who prescribe pharmaceutical preparations; outsourcing services in the nature of arranging service contracts or others in the field of pharmaceuticals; business administration of patient reimbursement programs for pharmaceuticals; business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient

Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; medical research in the fields of chemicals and pharmaceuticals; scientific research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; development of pharmaceutical products to specifications of others; research and development of pharmaceutical products for others.

Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely, epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely, epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer · treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products for the treatment of cardiovascular, central nervous system, infectious, metabolic, respiratory, gastrointestinal, inflammatory, oncologic, and pain related conditions, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatries, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents; pharmaceutical preparations for the treatment of cardiovascular, central nervous system, infectious, metabolic, respiratory, gastrointestinal, inflammatory, oncologic, and pain related conditions; pharmaceutical and medical preparations in connection with critical care, critical testing, maternal health, anesthesia, diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring and for rejuvenating to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities and in doctor's offices; pharmaceutical preparations, namely, analgesics and pain management preparations, preparations for the treatment of cancers, preparations for the treatment of urological diseases and disorders, preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, hormone replacement therapy preparations; drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated skin care gels and mineral supplements; food supplements; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents for the treatment of urinary urgency, breathing, saliva and secretion, gut motility, and heart rate, endocrinology, orthopedics, and urology, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, antiepileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents; pharmaceuticals preparations, namely, a blood clotting aid and delivery system for human use; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; prefilled syringe containing injectable pharmaceuticals for manual injection.

Manufacture of pharmaceutical products to the order and specification of others; providing technical information in the field of pharmaceutical manufacturing

Medical devices and apparatus, namely medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; Therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; medical devices for use in treating pelvic disorders; medical devices for use in treating pelvic organ prolapse; medical devices for use in treating urinary incontinence; medical devices for use in pain management and alleviation; medical devices, namely, intrauterine contraceptive devices; injection · syringes; injection device for pharmaceuticals and medicine; medical devices for use in treating critical care, critical testing, maternal health, anesthesia, diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring; all of which exclude robotic arms and surgical robots.

Providing health insurance information about health insurance benefits to patients; financial administration of patient reimbursement programs for pharmaceuticals; financial administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient; financial assistance programs that provide pharmaceuticals to help patients with insufficient resources to get treatment at little or no cost to the patient.

Providing medical information and medical information via a website on the subjects of pharmaceutical preparations and medicines, medical devices and techniques; providing medical information and online medical and healthcare information to healthcare professionals and patients; providing medical information via a website; providing medication counseling information, namely, advice and data on the subjects of pharmaceutical preparations and medicine; providing medical information on the subjects of aesthetic solutions to help patents feel better about their bodies.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2026 TROA
REFUSAL PROCESSED BY IB
Jun 18, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 2, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jun 2, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 21, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 20, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2026 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 13, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 13, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 13, 2026 COAR
APPLICATION FILING RECEIPT MAILED
Feb 26, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 26, 2026 REPR